PRMT1 and neuroblastoma: Indeed, we found that the currently available PRMT5 inhibitors, such as EPZ015666 were not able to recapitulate the sensitivity of human neuroblastoma cells in response to depletion of PRMT1 or PRMT5 (data not shown).